Biotech Values

[turtlepower]

RIGL - This article in medscape appears to indicate that certain biologics may be more effective in treating RA than methorexate. Assuming that is correct then the patients enrolled in taski3 may have more advanced RA than those enrolled in taski2. In which case the results probably may not be as good as taski2.

http://www.medscape.com/viewarticle/517506

Are there clear safety advantages over the current injectable drugs?